'To Robot or Not to Robot’: Radical Cystectomy for Muscle-Invasive Bladder Cancer- Bernard Bochner
(Length of discussion - 33 minutes)
Dr. Ashish Kamat welcomes Dr. Bernard Bochner in a discussion on robotic vs open radical cystectomy surgical options as a new standard of practice in the management of muscle-invasive bladder cancer (MIBC). He presents several studies and analyzes results with key oncologic outcomes in the forefront of his evaluation. He focuses on the differences in complications and recovery rates, functionality, and cost of one technique over the other. Dr. Bochner highlights a number of questions to be answered about the performance of this new therapy before labeling it the new standard of care. In this discussion oncologic and functional data from Robot-Assisted Radical Cystectomy (RARC) remains lacking and longer term prospective studies are needed to make a clear conclusion from an oncological standpoint.
Related Content: Radical Cystectomy for MIBC
Robotic-assisted radical cystectomy: Current technique and outcomes - Abstract
Society of Robotic Surgery 2017: State-of-the-Art Lecture: Improving Outcomes of Radical Cystectomy and Urinary Diversion With Robotics - Session Highlights
Bernard Bochner, MD. Attending Surgeon, Urology Services, Sir Murray Brennan Chair in Surgery, Department of Surgery, Memorial Sloan Kettering Cancer Center
Ashish Kamat, MD